HIGH

In immunocompromised patients with acute hypoxic respiratory failure (AHRF), does the use of high flow oxygen as opposed to standard oxygen therapy, reduce 28 day mortality?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
In immunocompromised patients with acute hypoxic respiratory failure (AHRF), does the use of high flow oxygen as opposed to standard oxygen therapy, reduce 28 day mortality?
Continue reading »In mechanically ventilated patients without acute respiratory distress syndrome (ARDS), does a low tidal volume ventilation strategy (6mL/Kg), compared to intermediate tidal volume strategy (10mL/Kg), reduce the number of ventilator-free and alive days at day 28?
Continue reading »In delirious adult ICU patients, does the administration of haloperidol or ziprasidone reduce the duration of delirium when compared with placebo?
Continue reading »In ICU patients at risk of gastrointestinal (GI) bleeding does the use of prophylactic proton-pump inhibitor (PPI) compared to placebo reduce mortality at 90 days?
Continue reading »patients with septic shock and severe acute kidney injury, does early vs. delayed renal replacement therapy improve 90 day mortality?
Continue reading »